MBBS SAQ · Obstetrics & Gynaecology
Primary postpartum haemorrhage — 4 Ts, uterotonics and tranexamic acid
NEET-PG SAQ on PPH: WHO definition, 4 Ts, oxytocin/ergometrine/carboprost/misoprostol with contraindications, TXA from WOMAN trial, balloon and surgical ladder.
On this page
Study tools
Exam tags
Write your answer
Saved on this device. No marking — you are the marker.
Question
A 32-year-old multiparous woman has a spontaneous vaginal delivery at term. Within 20 minutes she has estimated blood loss of 1200 mL. The uterus is soft and boggy above the umbilicus. Pulse 120, BP 88/50, RR 28, pale and sweaty. She is not hypertensive and has no asthma. Outline definition, likely cause, immediate resuscitation, drug therapy with doses/contraindications, and escalation if bleeding continues.
Model answer
Show the model answerShowHide
Definition: Primary PPH is blood loss ≥500 mL within 24 h of birth (vaginal) or ≥1000 mL after caesarean; major/severe often framed as ≥1000 mL or any loss with shock. Secondary PPH is from 24 h to 6 weeks (usually infection/retained tissue).[1][4]
Most likely cause — Tone (uterine atony, ~70%). Soft boggy uterus is pathognomonic. Apply the 4 Ts:
- Tone — atony (multiparity, prolonged labour, twins, polyhydramnios, chorioamnionitis, fibroids, tocolytics)
- Trauma — tears, extensions, rupture, inversion
- Tissue — retained placenta/clots
- Thrombin — coagulopathy (abruption, AFE, DIC, anticoagulation)
Immediate resuscitation (parallel, not sequential):
- Call for help — obstetric emergency team, anaesthesia, blood bank, midwifery.
- ABC, high-flow O₂, two large-bore IV cannulae, left lateral if still pregnant (not applicable postpartum), keep warm.
- Bloods: FBC, coagulation, fibrinogen, U&E, ABG/lactate; crossmatch 4–6 units; activate major obstetric haemorrhage protocol.
- IV crystalloid while blood arrives; early blood products aiming 1:1:1 RBC:FFP:platelets in massive haemorrhage; correct hypocalcaemia; target fibrinogen (often cryoprecipitate/fibrinogen concentrate if low).
- Rub up a contraction — bimanual uterine compression; empty bladder (catheter); examine placenta and lower genital tract simultaneously.
Drug ladder (uterotonics) + TXA:
- Oxytocin — 5 IU slow IV (or 10 IU IM) then infusion (e.g. 40 IU in 500 mL over 4 h) — first-line; avoid undiluted rapid boluses (hypotension).[1]
- Ergometrine 500 micrograms IM (or 250–500 micrograms) — contraindicated in hypertension/pre-eclampsia/cardiac disease.
- Carboprost (15-methyl PGF2α) 250 micrograms IM every 15 min, max 8 doses — contraindicated in asthma.
- Misoprostol 800 micrograms sublingual (or PR) — useful if no IV access / no cold chain; side effects pyrexia/shivering.
- Tranexamic acid 1 g IV over 10 min as soon as possible, ideally within 3 h of birth; second 1 g if bleeding continues after 30 min or restarts within 24 h — WOMAN trial: reduces death due to bleeding.[2]
If medical therapy fails — mechanical then surgical ladder:
- Intrauterine balloon tamponade (e.g. Bakri)
- Brace/compression sutures (B-Lynch)
- Stepwise devascularisation (uterine, tubo-ovarian, internal iliac artery ligation) / interventional radiology embolisation if available and stable enough for transfer
- Hysterectomy as life-saving last resort (do not delay too long)
- Always recheck trauma and retained tissue; correct coagulopathy (Thrombin)
Prevention note: active management of third stage (oxytocin at delivery) reduces PPH; E-MOTIVE bundle improves early detection/treatment in vaginal births.[3]
Common errors
- Giving ergometrine in pre-eclampsia or carboprost in asthma.
- Omitting tranexamic acid within 3 hours.
- Focusing only on drugs and missing genital-tract trauma or retained tissue.
- Delayed hysterectomy after prolonged ineffective temporising.
- Underestimating blood loss visually; not activating massive obstetric haemorrhage pathway.
Examiner notes
- Define PPH thresholds and list 4 Ts.
- Give drug + dose + route + contraindication for each uterotonic.
- Quote WOMAN: TXA 1 g IV within 3 h.
- State a clear escalation ladder ending in hysterectomy.
References4ShowHide
- [1]World Health Organization. (missing) WHO, 2012.PMID 23586122
- [2]WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality in women with PPH. Lancet, 2017.PMID 28456509
- [3]Gallos I, et al.; E-MOTIVE Collaborators. Randomized trial of early detection and treatment of postpartum hemorrhage. N Engl J Med, 2023.PMID 37158447
- [4]Escobar MF, et al. FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynaecol Obstet, 2022.PMID 35297039